MedTrace Logo

Prenatal Iron Supplements: Safety and Efficacy in Tanzania

NCT01119612 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1500

Last updated 2015-04-24

No results posted yet for this study

Summary

The purpose of this study is to determine safety and efficacy of prenatal iron supplementation in an area of high malaria burden among women who are not anemic or iron deficient.

Conditions

Interventions

DIETARY_SUPPLEMENT

Iron

Daily oral dose of 60 mg from enrollment until delivery

OTHER

Placebo

Daily oral dose from enrollment until delivery

Sponsors & Collaborators

  • Muhimbili University of Health and Allied Sciences

    collaborator OTHER

  • Harvard School of Public Health (HSPH)

    lead OTHER

Principal Investigators

  • Wafaie W Fawzi, MD, DrPH · Harvard School of Public Health (HSPH)

  • Zul Premji, MD, MSC, PhD · Muhimbili University of Health and Allied Sciences

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2013-03-31
Completion
2013-05-31

Countries

  • Tanzania

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01119612 on ClinicalTrials.gov